Skip to main content

Want a detailed portfolio tracker?

Revolution Medicines (RVMD) P/E (2020 - 2026)

Revolution Medicines (RVMD) P/E from Mar 31, 2020 to Jul 21, 2026. The TTM Revolution Medicines (RVMD) P/E is -25.98. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Revolution Medicines (RVMD)

YearP/EChange
2026-25.98+93.54%
2025-13.43+7.00%
2024-12.55+38.12%
2023-9.08+19.92%
2022-7.58-23.62%
2021-9.92-57.01%
2020-23.07N/A

Comparison Revolution Medicines (RVMD) P/E with competitors

Revolution Medicines (RVMD) P/E is -25.98.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.01%
NBYStablecoin Development Corp0.00-100.02%
ENLVEnlivex Ltd0.07-100.29%
FGENFibroGen Inc0.24-100.92%
CHRSCoherus Biosciences Inc0.85-103.27%
FBIOFortress Biotech Inc0.95-103.65%
ORMPOramed Pharmaceuticals Inc1.50-105.78%
AGENAgenus Inc3.01-111.58%
INVAInnoviva Inc3.15-112.14%
VXRTVaxart Inc3.55-113.66%
CRMDCorMedix Inc3.63-113.96%
CVACCureVac N.V.4.45-117.11%
GLPGGalapagos NV4.86-118.70%
SRPTSarepta Therapeutics Inc4.88-118.79%
ABEOAbeona Therapeutics Inc5.39-120.73%
ABUSArbutus Biopharma Corp5.60-121.53%
ZVRAZevra Therapeutics Inc5.89-122.66%
SPROSpero Therapeutics Inc6.23-123.97%
CGENCompugen Ltd6.31-124.30%
RIGLRigel Pharmaceuticals6.87-126.45%
SLXNSilexion Therapeutics Corp7.30-128.08%
OMEROmeros Corporation9.26-135.63%
AUPHAurinia Pharmaceuticals Inc9.58-136.89%
PLXProtalix BioTherapeutics Inc10.89-141.91%
ACADAcadia Pharmaceuticals Inc11.73-145.14%
TBPHTheravance Biopharma Inc12.26-147.19%
ADMAAdma Biologics Inc12.42-147.79%
HRMYHarmony Biosciences Holdings Inc13.82-153.18%
SABSSAB Biotherapeutics Inc14.14-154.40%
NAGENiagen Bioscience Inc14.82-157.03%
INCYIncyte Corp15.82-160.89%
REGNRegeneron Pharmaceuticals Inc15.86-161.02%
PBYIPuma Biotechnology Inc17.32-166.64%
CPRXCatalyst Pharmaceuticals Inc17.44-167.11%
EXELExelixis Inc17.54-167.49%
TGTXTG Therapeutics Inc18.97-172.99%
MDXGMimedx Group Inc20.55-179.09%
XOMAXOMA Royalty Corp22.87-188.03%
ARGXArgen X SE24.30-193.51%
CTMXCytomX Therapeutics Inc24.82-195.52%
XOMAOXOMA Royalty Corp25.34-197.54%
HALOHalozyme Therapeutics Inc25.62-198.61%
XOMAPXOMA Royalty Corp25.67-198.79%
VRTXVertex Pharmaceuticals Inc27.99-207.74%
RPRXRoyalty Pharma plc - Class A28.69-210.40%
SLNOSoleno Therapeutics Inc29.02-211.66%
ASNDAscendis Pharma A/S30.09-215.78%
LGNDLigand Pharmaceuticals Inc - Class B37.91-245.90%
APLSApellis Pharmaceuticals Inc39.02-250.17%
BMRNBiomarin Pharmaceutical Inc42.21-262.45%
KRYSKrystal Biotech Inc45.34-274.50%
ONCBeiGene Ltd69.54-367.62%
PHARPharming Group N.V.75.03-388.73%
TECHBio-Techne Corp101.96-492.38%
VCELVericel Corp109.92-523.03%
ALNYAlnylam Pharmaceuticals Inc117.96-553.98%
GMABGenmab140.29-639.90%
TLXTelix Pharmaceuticals Ltd162.15-724.04%
CORTCorcept Therapeutics Inc212.86-919.17%